Patents by Inventor Bruce Chandler May

Bruce Chandler May has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of levocetirizine and montelukast in the treatment of traumatic injury
    Patent number: 9937166
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: April 10, 2018
    Assignee: Inflammatory Response Research, Inc.
    Inventor: Bruce Chandler May
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 9925183
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: March 27, 2018
    Assignee: Inflammatory Response Research, Inc.
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS
    Publication number: 20170368059
    Abstract: The embodiments described herein include methods and formulations for treating anaphylaxis and related acute allergic reactions. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: July 13, 2017
    Publication date: December 28, 2017
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20170296534
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: May 2, 2017
    Publication date: October 19, 2017
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF VASCULITIS
    Publication number: 20170231980
    Abstract: The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: May 2, 2017
    Publication date: August 17, 2017
    Inventor: Bruce Chandler May
  • LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLAMMATION MEDIATED CONDITIONS
    Publication number: 20170173001
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: March 6, 2017
    Publication date: June 22, 2017
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of vasculitis
    Patent number: 9669025
    Abstract: The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: June 6, 2017
    Assignee: INFLAMMATORY RESPONSE RESEARCH, INC.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of autoimmune disorders
    Patent number: 9669026
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: June 6, 2017
    Assignee: INFLAMMATORY RESPONSE RESEARCH, INC.
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
    Publication number: 20170056395
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: November 10, 2016
    Publication date: March 2, 2017
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of traumatic injury
    Patent number: 9522148
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: December 20, 2016
    Assignee: INFLAMMATORY RESPONSE RESEARCH, INC.
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST TO AMELIORATE INFLAMMATION FOLLOWING RADIATION EXPOSURE
    Publication number: 20160175301
    Abstract: The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 23, 2016
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS
    Publication number: 20150352102
    Abstract: The embodiments described herein include methods and formulations for treating anaphylaxis and related acute allergic reactions. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: August 20, 2015
    Publication date: December 10, 2015
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20150352103
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: August 20, 2015
    Publication date: December 10, 2015
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
    Publication number: 20150352104
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: August 20, 2015
    Publication date: December 10, 2015
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF VASCULITIS
    Publication number: 20150352101
    Abstract: The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: August 20, 2015
    Publication date: December 10, 2015
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLUENZA, COMMON COLD AND INFLAMMATION
    Publication number: 20150231133
    Abstract: The embodiments described herein include methods and formulations for treating influenza, common cold and associated acute inflammation. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: May 5, 2015
    Publication date: August 20, 2015
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation
    Patent number: 9044479
    Abstract: The embodiments described herein include methods and formulations for treating influenza, common cold and associated acute inflammation. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: June 2, 2015
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLUENZA, COMMON COLD AND INFLAMMATION
    Publication number: 20130085124
    Abstract: The embodiments described herein include methods and formulations for treating influenza, common cold and associated acute inflammation. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: June 15, 2011
    Publication date: April 4, 2013
    Inventor: Bruce Chandler May